Update on endothelins

Drug Discovery Today

Volumn 2, Issue 3, 1997, Pages 85-87

  Willems, Henriëtte ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; BIG ENDOTHELIN 1; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; PD 069185; RECEPTOR SUBTYPE; RO 468443; TAK 044; UNCLASSIFIED DRUG;

BLOOD VESSEL TONE; DRUG ACTIVITY; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; SHORT SURVEY; VASCULAR RESISTANCE; VASODILATATION;

EID: 0031104575     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(97)84784-8     Document Type: Article

References (8)

1. 1 Davenport, A.P. et al. (1995) J. Cardiovasc. Pharmacol. 26 (S3), S265-S267
2. 2 Bacon, C.R., Cary, N.R.B. and Davenport, A.P. (1996) Circ. Res. 79, 794-801
3. 3 Peto, H. et al. (1996) FEBS Lett. 394, 191-195
4. 4 Clozel, M. et al. (1994) J. Pharmacol. Exp. Ther. 270, 228-235
5. 5 Clozel, M. and Breu, V. (1996) FEBS Lett. 383, 42-45
6. 6 Kurihara, Y. et al. (1994) Nature 368, 703-710
7. 7 Ohlstein, E.H. et al. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8052-8056
8. 8 Haynes, W.G. et al. (1996) Circulation 93, 1860-1870